Chapter III: Management of cardiovascular risk factors and medical therapy (Q27015689)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Chapter III: Management of cardiovascular risk factors and medical therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author

Hans-Henning Eckstein

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Martin Teraa

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Florian Dick

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

12

F L Moll

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

N Diehm

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J Schmidli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

C Setacci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J-B Ricco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

G de Donato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

F Becker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Robert-Ebadi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P Cao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P De Rango

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A H Davies

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

M Lepäntalo

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J Apelqvist

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

1 reference

1 December 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Vascular and Endovascular Surgery

18 January 2020

published in

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

42 Suppl 2

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

S33-42

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22172471%20AND%20SRC:MED&resulttype=core&format=json

The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Smoking and the patency of lower extremity bypass grafts: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Nicotine receptor partial agonists for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Short-term change in self-reported COPD symptoms after smoking cessation in an internet sample.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Early improvement in peripheral vascular tone following smoking cessation using nicotine replacement therapy: aortic wave reflection analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Basic science review: Statin therapy--Part I: The pleiotropic effects of statins in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by i

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Beta-adrenergic blockers and intermittent claudication. Time for reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Beta blockers for peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Soc

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Effect of a multifactorial intervention on mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Long-term effects of intensive glucose lowering on cardiovascular outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Oral anticoagulant and antiplatelet therapy and peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Platelet inhibition with ASA/dipyridamole after percutaneous balloon angioplasty in patients with symptomatic lower limb arterial disease. A prospective double-blind trial. Study group on pharmacological treatment after PTA

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Controlled trial of high-versus low-dose aspirin treatment after percutaneous transluminal angioplasty in patients with peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Meta-analysis of randomised controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Stem cell therapy in PAD.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Coronary-artery revascularization before elective major vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

The Effect of Bisoprolol on Perioperative Mortality and Myocardial Infarction in High-Risk Patients Undergoing Vascular Surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Optimizing long-term cardiac management after major vascular surgery: Role of beta-blocker therapy, clinical characteristics, and dobutamine stress echocardiography to optimize long-term cardiac management after major vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society f

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Guidelines for the Reporting of Renal Artery Revascularization in Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Angioplasty and STent for Renal Artery Lesions (ASTRAL trial): rationale, methods and results so far.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Economic implications of evidence-based prescribing for hypertension: can better care cost less?

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Statins for Cardiovascular Prevention According to Different Strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021

Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1078-5884%2811%2960011-7

7 January 2021